Watch ROIV. Know when insiders buy.
One email the day a filing lands. Free.
ROIV
Roivant Sciences Ltd.
36.80
+1.88 +5.38%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
27
FLAG · insiders 25, shorts 28
Insiders, 90 days
−$28.7M
net selling · 0 buys, 13 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $26.6BP/E —DIV YIELD —FCF YIELD -3.09%REV TTM $7.5M −67.6%NET INCOME −$266.3MNET CASH $936.7M52W 17.87 – 41.81NEXT EARNINGS Nov 9 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$28.7M
Net, 90 days
0 / 13
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1 | Oct 5 | Epperly Melissa B, · Director | Sell | 900 | $36.57 | $33K |
| Oct 1 | Oct 5 | Epperly Melissa B, · Director | Sell | 16,850 | $36.08 | $608K |
| Sep 30 | Oct 2 | Venker Eric · President & Immunovant CEO | Sell | 200,000 | $36.62 | $7.3M |
| Sep 15 | Sep 17 | Fitzgerald Meghan · Director | Sell | 400 | $40.45 | $16K |
| Sep 15 | Sep 17 | Fitzgerald Meghan · Director | Sell | 4,712 | $39.68 | $187K |
| Sep 15 | Sep 17 | Epperly Melissa B, · Director | Sell | 600 | $40.38 | $24K |
| Sep 15 | Sep 17 | Epperly Melissa B, · Director | Sell | 4,338 | $39.65 | $172K |
| Sep 8 | Sep 10 | Fitzgerald Meghan · Director | Sell | 20,000 | $39.90 | $798K |
| Aug 28 | Sep 1 | Venker Eric · President & Immunovant CEO | Sell | 33,818 | $36.44 | $1.2M |
| Aug 28 | Sep 1 | Venker Eric · President & Immunovant CEO | Sell | 166,182 | $35.63 | $5.9M |
| Aug 21 | Aug 21 | Sukhatme Mayukh · President & CIO | Sell | 144,756 | $36.48 | $5.3M |
| Aug 20 | Aug 21 | Sukhatme Mayukh · President & CIO | Sell | 17,519 | $37.30 | $653K |
| Aug 19 | Aug 21 | Sukhatme Mayukh · President & CIO | Sell | 172,899 | $37.17 | $6.4M |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.